meta_pixel
Tapesearch Logo
Log in
Industry Focus

Healthcare: Tax Reform Takes a Bite Out of Biotech

Industry Focus

The Motley Fool

Interview, Money, Consumergoods, Business, Businessnews, Ceo, Technology, Investing, Stocks, Energy, Fool, Financial, Economy, Healthcare, News, Banking, Motley, Tech, Business News, Investments

4.6854 Ratings

🗓️ 6 December 2017

⏱️ 28 minutes

🧾️ Download transcript

Summary

The tax bill includes fine print that could make biopharma companies pay more in taxes than expected. Plus, CVS Health cozies up to Aetna and Apple takes aim at heart disease.

Transcript

Click on a timestamp to play from that location

0:00.0

This episode of Industry Focus is brought to you by Casper, a sleep brand that continues to revolutionize its line of products to create an exceptionally comfortable sleep experience one night at a time.

0:10.0

Get $50 off any mattress purchase by visiting Casper.com slash fool and using promo code

0:15.6

fool at checkout.

0:19.4

Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day.

0:24.4

It's Wednesday, December 6th, and we're talking about three big news items in health care,

0:28.1

Aetna CBS, Tax Reform, and an Apple Heart Study.

0:31.7

I'm your guest host, Michael, Christine's sick today so I'm

0:34.4

filling in for her. Sorry everybody and I'm joined by Todd Campbell. Todd good to have you.

0:39.7

Michael, great to be here and great to be able to chat with you today.

0:43.4

For a second there, I thought maybe you lost your way

0:45.8

on the way to film the financial show.

0:48.0

Yes, as probably many listeners were sort of questioning that at the beginning to

0:53.2

they were like wait a minute I've heard this guy recently okay so let's start off

0:57.7

with the big news item that really for industry focus listeners isn't necessarily a huge big news item.

1:04.7

At N, and CVS are officially planning to merge.

1:06.8

We'll talk about it very quickly because you and Christina obviously covered this heavily

1:11.4

recently and Christine actually was on the market foolery show yesterday to talk about it.

1:15.2

So listeners if you're looking for more details check out those shows.

1:18.2

But it looks like things are officially planned at least at CVS is offering $145 in cash per share

1:27.0

plus 0.8 378 CVS shares that's roughly $2007 per share of Aetna.

1:35.0

Yeah, a tiny deal, right?

1:37.0

Yeah.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.